The result of immunohistochemical staining for CD138+ plasma cells showed that 60.6% of patients converted to CE negative after PRP treatment, suggesting that the PRP treatment plays a positive role in treating persistent CE. This evidence concerns the gene SDC1 and cholesteryl ester measurement.